Patents by Inventor Zhengcai ZHANG

Zhengcai ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240161315
    Abstract: A moving object tracking approach for a quadrupedal robot based on a Siamese network comprises an RNN-based object detector for locating moving objects. The position information of moving objects is sent into a ResNet-based feature extractor. For regressing bounding boxes of a target object, a Siamese adaptive network is employed. Experimental results on several public benchmarks show that this approach achieves excellent VOT performances, e.g., it obtains EAO score by 0.452 points, Accuracy score by 0.592 points, and Robustness score by 0.155 points on public benchmark VOT2018. it is successfully used on a quadrupedal robot, which can accurately track a specific moving object in real-world complicated scenes.
    Type: Application
    Filed: December 19, 2023
    Publication date: May 16, 2024
    Applicant: BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY
    Inventors: Zhengcai CAO, Junnian LI, Shibo SHAO, Dong ZHANG, Chengran LIN, Renjie JU, Guofeng DU, Ji XIA
  • Patent number: 9968717
    Abstract: Disclosed is a stent with a drug coating for preventing and treating restenosis, comprising a stent and a drug coating covering the surface of the stent. The active ingredients in the drug coating are guaiane sesquiterpene compounds P1, P2 and P3. P1 is Zedoalactone B, P2 is a stereoisomer of P1, and P3 is Zedoarondiol. Compared with an existing sirolimus eluting stent, the present drug eluting stent can inhibit the intimal hyperplasia and the inflammatory reactions of vascular walls, and promote the endothelialization of blood vessels after the stent is implanted, and thus can prevent the long-term thrombotic complications; and has the advantages of small dosage, low cost, and no toxic side effect.
    Type: Grant
    Filed: April 20, 2015
    Date of Patent: May 15, 2018
    Assignee: Xiyuan Hospital of China Academy of Chinese Medical Sciences
    Inventors: Dazhuo Shi, Jiangang Liu, Fuhai Zhao, Xin Wang, Dawu Zhang, Peili Wang, Jianpeng Du, Yuanyuan Cui, Lei Zhang, Kai Cui, Zhengcai Zhang
  • Publication number: 20170216497
    Abstract: Disclosed is a stent with a drug coating for preventing and treating restenosis, comprising, a stent and a drug coating covering the surface of the stent. The active ingredients in the drug coating are guaiane sesquiterpene compounds P1, P2 and P3. P1 is Zedoalactone B, P2 is a stereoisomer of P1, and P3 is Zedoarondiol. Compared with an existing sirolimus eluting stent, the present drug eluting stent can inhibit the intimal hyperplasia and the inflammatory reactions of vascular walls, and promote the endothelialization of blood vessels after the stent is implanted, and thus can prevent the long-term thrombotic complications; and has the advantages of small dosage, low cost, and no toxic side effect.
    Type: Application
    Filed: April 20, 2015
    Publication date: August 3, 2017
    Applicant: XIYUAN HOSPITAL OF CHINA ACADEMY OF CHINESE MEDICAL SCIENCES
    Inventors: Dazhuo SHI, Jiangang LIU, Fuhai ZHAO, Xin WANG, Dawu ZHANG, Peili WANG, Jianpeng DU, Yuanyuan CUI, Lei ZHANG, Kai CUI, Zhengcai ZHANG